Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-12 Sale | 2022-07-14 8:35 pm | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 321,770 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-05-11 5:25 pm | N/A N/A | Bioceres Crop Solutions Corp. | BIOX | Mago Yogesh Director | 0 | $0 | 55,399 (Direct) | View |
| 2022-07-12 Exercise | 2022-07-14 8:35 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 321,770 | $0 | 0 (Direct) | View |
| 2022-07-12 Option Award | 2022-07-14 8:35 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 321,770 | $0 | 0 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 4:27 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 10,250 | $0 | 10,250 (Direct) | View |
| 2022-04-06 Option Award | 2022-04-08 4:16 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 35,250 | $0 | 35,250 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 4:14 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 10,250 | $0 | 10,250 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 5:35 pm | N/A N/A | MARRONE BIO INNOVATIONS INC | MBII | Mago Yogesh Director | 10,250 | $0 | 10,250 (Direct) | View |